Showing posts with label common. Show all posts
Showing posts with label common. Show all posts

Friday, September 20, 2013

0 Severe contact dermatitis due to camomile: a common complementary remedy with potential sensitization risks

Open Access


Short report


Severe contact dermatitis due to camomile: a common complementary remedy with potential sensitization risks



Sibel Dogan












Allergy, Asthma & Clinical Immunology 2013, 9:26 doi:10.1186/1710-1492-9-26

Published: 15 July 2013





Abstract (provisional)


Camomile extracts and compositae mix containing herbal remedies are used for several alternative/complementary therapies for a long time. In fact, camomile has been used traditionally in eastern Anatolia as a pain relieving topical anesthetic agent. Besides becoming a popular herbal remedy, camomile is also known for its potential in inducing chemical burn, irritant and allergic contact dermatitis, conjunctivitis and anaphylaxis. Different clinical apperances of camomile allergy was reviewed with three patients using the same topical camomile remedy in this report. It is important to remember that home-made crushed camomile preparations can lead both sensitization and acute allergic contact dermatitis as well.






The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.



Tuesday, September 17, 2013

0 A review on guidelines for management and treatment of common variable immunodeficiency



Summary


June 2013, Vol. 9, No. 6, Pages 561-575 , DOI 10.1586/eci.13.30

(doi:10.1586/eci.13.30)





Review

  

A review on guidelines for management and treatment of common variable immunodeficiency



Hassan Abolhassani1, Babak Torabi Sagvand1, Tahaamin Shokuhfar1, Babak Mirminachi1, Nima Rezaei1,2 and Asghar Aghamohammadi*1


* Author for correspondence



Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency in adults. As symptoms of CVID are usually heterogeneous and unspecific, diagnosis and follow-up of CVID can be challenging. In light of this, a broad review of advances in management and treatment of CVID is performed here in order to reach a distinct protocol. However, it should be noted that owing to the nature of the disease, it can only be treated symptomatically but not cured. There is little evidence to guide appropriate or universal guidelines to improve the current status of management of the disease. The most satisfactory treatments of CVID could be achieved by the use of immunoglobulin replacement, antibiotics, immunosuppressants and hematopoietic stem cell transplantation. This review is written based on the importance of clinical surveillance of asymptomatic CVID cases and early recognition of different clinical complications. Moreover, for each complication, appropriate interventions for improving outcomes are mentioned.







Full TextPDF (4044 KB)PDF Plus (4166 KB)